Description
Osimertinib tablets are used to treat non-small cell lung cancer (NSCLC) with specific mutations in the EGFR gene, particularly the T790M mutation. It works by inhibiting the mutated EGFR receptor, blocking cancer cell growth and spread. It’s commonly prescribed for advanced or metastatic NSCLC.